Original Research
Published on 09 Feb 2021
Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
in Movement Disorders
Frontiers in Neurology
doi 10.3389/fneur.2021.636590
- 8,470 views
- 21 citations
